The U.S. Food and Drug Administration (FDA) is again concerned about the safety of four popular asthma inhalers. Two federal safety officials wrote an assessment that claimed patients were risking death if they continued to take Advair, Symbicort, Serevent and Foradil. A third official recommended that Advair and Symbicort should be used only by adults, and by patients who suffer from chronic obstructive pulmonary disease. As a result of the disgareement, an FDA advisory panel is scheduled to...
Read moreAlthough asthma death rates have declined, it continues to be a leading cause of missed work and school in the United States. The National... Read more »
Chances are if you have asthma you have some degree of chronic (it's always there) inflammation in your air passages. Studies have... Read more »
Some of the most effective asthma medicines are inhaled steroids, and the downside to this is that the word "steroid" has a bad reputation.... Read more »
Black box warnings are a type of labeling that the Federal Drug Administration (FDA, for short) requires pharmaceutical companies to use... Read more »
It would be neat if asthma was like a sport. Instead of writing dry, humorless posts, we could write exciting and entertaining posts... Read more »
A recent Scottish study suggests children with allergic conditions may be receiving steroid doses that are too high. Researchers say one in 11... Read more »
A bronchdodilator is a quick-relief asthma medicine that relaxes the airways in the lungs so it's easier to breathe. They are often prescribed in... Read more »
Read the full text of How to Spot a Bronchodilatoraholic and leave a comment! Read all of Rick Frea's posts Visit Repiratory Therapy Cave, Rick... Read more »
Have questions or comments? Click here. Last week the Food and Drug Administration (FDA) listened to presentations and comments from several members... Read more »
The Food and Drug Administration has censured three national pharmacies for producing thousands of unapproved copies of commercially available... Read more »